EHR-integrated rUTI Texting Platform

Description

The goal of this clinical trial is to compare a texting platform to usual care for managing recurrent urinary tract infections (UTI). The main question it aims to answer is: • can a texting platform that integrates symptom triage and prevention education reduce the rate of unnecessary antibiotics for recurrent UTIs as compared to usual care? Participants enrolled onto the texting platform will: • receive evidence-based clinical guidance for the management of symptoms of UTI and receive educational videos on how to prevent UTIs. An important secondary outcome is to determine if the texting platform improves self-efficacy for the management of recurrent UTI.

Conditions

Recurrent Urinary Tract Infection

Talk to us

Study Overview

On this page

Study Details

Study overview

The goal of this clinical trial is to compare a texting platform to usual care for managing recurrent urinary tract infections (UTI). The main question it aims to answer is: • can a texting platform that integrates symptom triage and prevention education reduce the rate of unnecessary antibiotics for recurrent UTIs as compared to usual care? Participants enrolled onto the texting platform will: • receive evidence-based clinical guidance for the management of symptoms of UTI and receive educational videos on how to prevent UTIs. An important secondary outcome is to determine if the texting platform improves self-efficacy for the management of recurrent UTI.

An EHR-integrated Texting Platform to Promote Self-management in Women With Recurrent Urinary Tract Infections

EHR-integrated rUTI Texting Platform

Condition
Recurrent Urinary Tract Infection
Intervention / Treatment

-

Contacts and Locations

Philadelphia

University of Pennsylvania, Philadelphia, Pennsylvania, United States, 19104

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Provision of signed and dated informed consent form
  • 2. Stated willingness to comply with all study procedures and availability for the duration of the study
  • 3. Females who currently meet the criteria for recurrent UTIs
  • 4. Age 18 years or older
  • 5. Owns a mobile device with text messaging capability
  • 6. Ability to read and write English
  • 7. Currently receiving care from a provider in Penn Urogynecology or Penn Urology
  • 1. History of known multidrug resistant UTIs
  • 2. History of interstitial cystitis/bladder pain syndrome or current diagnosis of chronic pelvic pain
  • 3. On continuous suppressive antibiotics currently
  • 4. Currently pregnant or within 6 weeks of pregnancy
  • 5. Transplant patient on immunosuppressive medication currently
  • 6. Practice of chronic self-catheterization

Ages Eligible for Study

18 Years to 100 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of Pennsylvania,

Study Record Dates

2026-06-15